CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- 4 Exercise or conversion Director acquired 10,841 shares (option exercise)
- 4 Exercise or conversion Director acquired 10,841 shares (option exercise)
- 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
- 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
- 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
- 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
- 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
- 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
- 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
- 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
- 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
- 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
- 4 Open-market buy Chief Medical Officer bought 6,500 shares at $2.93 ($19,045)
- 4 Open-market buy Director bought 100,000 shares at an average $2.59 ($258,529)
- 4 Grant or award Chief Operating Officer acquired 140,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 36,000 shares at an average $1.54 ($55,586)
- 4 Open-market buy Director bought 19,000 shares at an average $1.45 ($27,588)
- 4 Open-market buy Chief Medical Officer bought 3,500 shares at $1.54 ($5,402)
- 4 Open-market buy Director bought 45,000 shares at an average $1.48 ($66,434)
Page 4 of 22 · 436 filings